Cambridge-based cell uye gene therapy inobata kambani ElevateBio, uye AgBiome, mutungamiri mukugadzira zvigadzirwa zvitsva kubva munharaunda dzezvisikwa zvipenyu, akazivisa Nov. 16 kuti LifeEDIT Therapeutics yakabatana neElevateBio's kukura kwekambani yemakambani.
Zvinoenderana nekuburitswa kwenhau kubva kuAgBiome, LifeEDIT Therapeutics inosanganisa yakasarudzika genome editing chikuva, yakatorwa kubva kuAgBiome's proprietary library of microbes, nehunyanzvi hweElevateBio mukuwanikidzwa nekuvandudzwa kwesero idzva uye gene kurapwa.
LifeEDIT icharamba ichivandudza mukati mesero uye gene marapiro apo ichisimbisa chikuva chayo cheakasiyana genome-editing enzymes uye nekupa hunyanzvi hwekugadziridza majini kune vane hunyanzvi vanosanganisira makambani eElevateBio portfolio, sekuburitswa kwenhau. AgBiome inochengetedza kodzero dzekugadzirisa majini mune zvekurima, hutano hwemhuka, uye kuongororwa. Zvigadzirwa zveAgBiome zvinosanganisira Howler, biofungicide yezvirimwa zvakakosha.
"LifeEDIT's genome editing platform ndeimwe yeanonyanya kushandiswa mumunda uye yaive yakanyatsokodzera isu tichiramba tichivaka sero rinotungamira pasi rose uye jena therapy inopa," akadaro Mitchell Finer, purezidhendi weElevateBio BaseCamp, uye achangobva kugadzwa Chief Executive. Mukuru weLifeEDIT Therapeutics.
Zvinoenderana nekuburitswa kwenhau, nhengo dzeElevateBio dzichabatana neiyo ichangobva kuumbwa LifeEDIT Therapeutics manejimendi timu. Iyo yakasanganiswa Executive timu inosanganisira:
- Mitchell Finer, Ph.D., Chief Executive Officer, LifeEDIT Therapeutics uye Mutungamiri, ElevateBio BaseCamp.
- Tedd Elich, Ph.D., Chief Scientific Officer, LifeEDIT Therapeutics.
- Kareem Reda, Chief Operating Officer, LifeEDIT Therapeutics uye Chief Business Officer, ElevateBio.
- Clare Murray, Mutevedzeri weMutungamiri, Musoro weCorporate Development uye Strategy, LifeEDIT Therapeutics.